Alcohol Withdrawal Syndrome (DBCOND0031371)

Identifiers

Synonyms
Alcohol Withdrawal Syndrome(AWS) / Alcohol Withdrawal / Alcohol withdrawal syndrome / Alcohol withdrawal syndrome (disorder)

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Atenolol
A synthetic beta-1 selective blocker used in the management of hypertension and chronic angina, and to reduce mortality in known or suspected myocardial infarction in hemodynamically stable patients.
Carbamazepine
An anticonvulsant used to treat various types of seizures and pain resulting from trigeminal neuralgia.
Caroverine
A calcium channel blocker indicated in the treatment of smooth muscle spasms, alcohol and drug withdrawal, and tinnitus.
Chloral hydrate
A mild hypnotic used for experimental purposes that was previously used for the treatment of insomnia.
No drug targets
Chlordiazepoxide
A benzodiazepine used to treat the withdrawal symptoms of acute alcoholism, to treat preoperative anxiety, and to treat anxiety over a short term period.
Dexmedetomidine
An alpha-2 agonist used for sedation during various procedures.
Lorazepam
A short-acting benzodiazepine commonly used to treat panic disorders, severe anxiety, and seizures.
Oxazepam
An intermediate-acting benzodiazepine with slow onset commonly used to treat panic disorders, severe anxiety, alcohol withdrawals, and insomnia.
Phenobarbital
A long-lasting barbiturate and anticonvulsant used in the treatment of all types of seizures, except for absent seizures.
Piracetam
A nootropic cyclic GABA derivative used in myoclonus, sickle cell disease, alcohol dependence, and as a general cognitive enhancer.
No drug targets
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT00409370
Trial of Safety Nets In Hospitalized PatientsNo drug interventionssupportive_care3completed
NCT00229125
Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepamtreatment2completed
NCT03737864
NCARE, Transition to RecoveryNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT05216705
Study of Exploratory Plasmatic Markers of Alcohol WithdrawalNo drug interventionsNot AvailableNot Availablecompleted
NCT03466528
Alcohol: Thiamine and or Magnesium 1treatment2 / 3completed
NCT04793685
Prazosin for Alcohol Use Disorder With Withdrawal Symptomstreatment1 / 2recruiting
NCT01212185
Oxytocin Treatment of Alcohol Withdrawaltreatment1completed
NCT03521115
Family Based Prevention of Alcohol and Risky Sex for Older TeensNo drug interventionspreventionNot Availablecompleted
NCT01573052
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawaltreatment4completed
NCT04232800
Riboflavin for Glutamate Reduction in Alcohol Withdrawalbasic_science2unknown_status
NCT01184417
Phenobarbital for Acute Alcohol WithdrawaltreatmentNot Availablecompleted
NCT03916939
Osteopathic Treatment to Alcohol Withdrawal SyndromeNo drug interventionsotherNot Availableunknown_status
NCT04205682
Cannabidiol (CBD) for the Treatment of Alcohol Withdrawaltreatment0unknown_status
NCT06173973
Effects of Ketone Supplementation on Acute Alcohol WithdrawalNo drug interventionsbasic_science2 / 3enrolling_by_invitation
NCT05393544
Digitally Assisted Recovery CoachNo drug interventionstreatmentNot Availablecompleted
NCT06559995
Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use DisorderNo drug interventionsbasic_science2 / 3not_yet_recruiting
NCT04858490
Remote Treatment of Alcohol WithdrawaltreatmentNot Availablecompleted
NCT01937364
Preventing Alcohol Withdrawal With Oral Baclofenprevention2terminated
NCT04156464
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unittreatment4unknown_status
NCT02349477
Gabapentin for Alcohol Relapse Preventiontreatment2completed
NCT02823977
Ketamine vs. Placebo as Adjunctive Therapies for Severe Alcohol Withdrawaltreatment4withdrawn
NCT03971097
The Effect of Self-Forgiveness on Self-Stigma in Addiction.No drug interventionstreatmentNot Availablecompleted
NCT02275611
Oxytocin Treatment of Alcohol Dependencetreatment2completed
NCT04159909
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol WithdrawalNo drug interventionstreatmentNot Availablewithdrawn
NCT00523185
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol WithdrawaltreatmentNot Availablecompleted
NCT03293017
Baclofen in Managing Acute Alcohol Withdrawaltreatment4unknown_status
NCT00136617
Outpatient Treatment of Alcohol Withdrawal Syndrometreatment3completed
NCT05131334
Auricular Vagal Stimulation in Alcohol CravingNo drug interventionsdiagnosticNot Availablecompleted
NCT03878225
Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans?No drug interventionstreatmentNot Availableunknown_status
NCT04997330
Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive DysfunctionNo drug interventionstreatmentNot Availableunknown_status
NCT02202148
Liver Stiffness Measurement in Alcohol-dependent Subjects in Relation to Abstinence After WithdrawalNo drug interventionsNot AvailableNot Availablecompleted
NCT02835365
Observational Study on Patients With Baclofen Treatment for Alcohol-dependence in FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT03586089
Phenobarbital for Severe Acute Alcohol Withdrawal SyndrometreatmentNot Availableterminated
NCT05563350
Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal SymptomsNo drug interventionsNot AvailableNot Availablecompleted
NCT04876443
Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)No drug interventionsNot AvailableNot Availableunknown_status
NCT06589973
Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome PatientsNo drug interventionsNot AvailableNot Availablerecruiting
NCT04973202
Portrayal of Hospital Alcohol Detoxification in FranceNo drug interventionsNot AvailableNot Availablecompleted
NCT00146471
Efficacy and Safety of Levetiracetam in the Inpatient Treatment of Alcohol Withdrawal Syndrometreatment3completed
NCT01637415
The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS)No drug interventionsNot AvailableNot Availablecompleted
NCT05438641
Treatment of Alcohol Withdrawal Syndrome With Alpha-2 Agonists and/or AnticonvulsantsNo drug interventionsNot AvailableNot Availablecompleted
NCT01652326
Clinical Quality Improvement of Benzodiazepine-Resistant Alcohol Withdrawal SyndromeNot AvailableNot Availablecompleted
NCT03235531
Assessment of Valproate on Ethanol Withdrawalprevention4unknown_status
NCT03788889
Alcohol Withdrawal Syndrome Treated With Adjunctive Phenobarbital or Ketaminetreatment4withdrawn
NCT02052440
Preventing Alcohol Withdrawal Syndrome With Oral Baclofentreatment3terminated
NCT02090504
Comparative Study of Gamma-hydroxy Butyrate Versus Oxazepam in the Treatment of Alcohol Withdrawal Syndrometreatment4completed
NCT06555679
Evaluation of a Predictive Score for the Onset of Moderate to Severe Alcohol Withdrawal Syndrome, the PAWSS, in a Population of Intensive Care Patients at Brest University HospitalNo drug interventionsNot AvailableNot Availablecompleted
NCT03012815
Gabapentin for Alcohol Withdrawal Syndrometreatment4completed
NCT02146716
Assessment of Energetic Resonance by Cutaneous Stimulation on Withdrawal Alcohol Symptoms.No drug interventionssupportive_careNot Availablecompleted
NCT00249366
Treatment of Alcohol Withdrawal in Hospital Patientstreatment4completed
NCT03033823
MAGnesium Adjunction in Alcohol Withdrawal Syndrome: a Multicenter Assessment (MAGMA)treatment3completed